(VIANEWS) – GOODTECH (GOD.OL), SPAREBANKEN VEST (SVEG.OL), SARTORIUS STED BIO (DIM.PA) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. GOODTECH (GOD.OL)
30% sales growth and 11.86% return on equity
Goodtech ASA provides management systems, digitization, and production optimization solutions for industrial and manufacturing companies in Norway, Sweden, Finland, Europe, and internationally. The company provides a range of in-house developed and partner-driven technologies and customized solutions for automation of production, which include construction, installation, service, and maintenance; development, project management, and engineering services; and technology and customized solutions, such as streamlining production, material handling, warehousing, and logistics solutions, as well as packaging machines. It also offers robotic systems for handling, controlling, and logistics of bulk materials under the Portabulk brand; power and electrical, automation, and system integration solutions to industry and power distributors; constructs and rehabilitates transformer stations. In addition, the company provides products and solutions for drinking water and wastewater treatment, and various industrial water. It serves a range of customers within aquaculture, food, pharmacy and health, renewable energy, district heating, oil and gas, power, water treatment, chemical, cable production, automotive, machinery, metal, and mineral industries. Goodtech ASA was founded in 1913 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, GOODTECH has a trailing twelve months EPS of kr1.2.
PE Ratio
GOODTECH has a trailing twelve months price to earnings ratio of 11.5. Meaning, the purchaser of the share is investing kr11.5 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.86%.
Moving Average
GOODTECH’s value is higher than its 50-day moving average of kr13.38 and way higher than its 200-day moving average of kr11.39.
Volume
Today’s last reported volume for GOODTECH is 304143 which is 486.07% above its average volume of 51895.
Yearly Top and Bottom Value
GOODTECH’s stock is valued at kr13.80 at 17:20 EST, under its 52-week high of kr15.00 and way higher than its 52-week low of kr9.44.
More news about GOODTECH.
2. SPAREBANKEN VEST (SVEG.OL)
18.1% sales growth and 17.74% return on equity
Sparebanken Vest, a financial services company, provides banking and financing services in the counties of Vestland and Rogaland, Norway. The company operates through Corporate Market, Retail Market, Bulder Bank, Treasury, and Estate Agency Activities segments. It is also involved in home mortgage activities. Sparebanken Vest was founded in 1823 and is headquartered in Bergen, Norway.
Earnings Per Share
As for profitability, SPAREBANKEN VEST has a trailing twelve months EPS of kr14.02.
PE Ratio
SPAREBANKEN VEST has a trailing twelve months price to earnings ratio of 9.45. Meaning, the purchaser of the share is investing kr9.45 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.74%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 23.6% and 10.7%, respectively.
More news about SPAREBANKEN VEST.
3. SARTORIUS STED BIO (DIM.PA)
12.2% sales growth and 8.15% return on equity
Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; biolayer interferometry instruments; microbiology enumeration, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; biomolecule analysis tools; flow cytometry; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; and weighing products. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production; process automation platform and software; and develops and produces transfection, as well as other DNA/RNA delivery reagents and plasmid DNA. It serves manufacturers of medications, vaccines, foods, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. As of December 31, 2023, Sartorius Stedim Biotech S.A. operates as a subsidiary of Sartorius AG.
Earnings Per Share
As for profitability, SARTORIUS STED BIO has a trailing twelve months EPS of €3.36.
PE Ratio
SARTORIUS STED BIO has a trailing twelve months price to earnings ratio of 78.66. Meaning, the purchaser of the share is investing €78.66 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.15%.
More news about SARTORIUS STED BIO.
